Literature DB >> 29358564

Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.

Virginia Sedeno-Monge1, Veronica Vallejo-Ruiz, Francisca Sosa-Jurado, Gerardo Santos-Lopez.   

Abstract

Little is known about the mechanisms underlying hepatocellular carcinoma (HCC). Some studies have focused on the role of HCV viral proteins in hepatocyte transformation. In this work we have compiled and analysed current articles regarding the impact of polymorphisms in the HCV core gene and protein on the development of HCC. An exhaustive search for fulltext articles until November 2016 in PubMed database was performed using the MeSH keywords: 'hepatitis C', 'polymorphisms', 'core', 'hepatocellular cancer' and 'hepatocarcinogenesis'. Nineteen full-text articles published between 2000 and 2016 were considered. Different articles associate not only the HCC development with polymorphisms at residues 70 and 91 in the core protein, but more with mortality and treatment response. Also, different polymorphisms were found in core and other viral proteins related to HCC development. Eleven articles reported that HCC development is significantly associated with Gln/His70, four associated it with Leu91 and two more associated it with both markers together. Additional studies are necessary, including those in different types of populations worldwide, to validate the possibility of the usability and influence in chronically HCV-infected patients as well as to observe their interaction with other risk factors or prognosis and genetic markers of the host.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29358564     DOI: 10.1007/s12038-017-9695-4

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  89 in total

1.  Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

Authors:  H Okamoto; N Kanai; S Mishiro
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  Characteristics of hepatitis C viral genome associated with disease progression.

Authors:  K Nagayama; M Kurosaki; N Enomoto; Y Miyasaka; F Marumo; C Sato
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

3.  Amino acid substitutions in the hepatitis C virus core region are associated with postoperative recurrence and survival of patients with HCV genotype 1b-associated hepatocellular carcinoma.

Authors:  Hidenori Toyoda; Takashi Kumada; Yuji Kaneoka; Atsuyuki Maeda
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

4.  Amino acid substitutions in the Hepatitis C virus core region of genotype 1b in Moroccan patients.

Authors:  Ikram Brahim; Sayeh Ezzikouri; El Mostafa Mtairag; Rhimou Alaoui; Salwa Nadir; Pascal Pineau; Soumaya Benjelloun
Journal:  Infect Genet Evol       Date:  2012-11-10       Impact factor: 3.342

5.  Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.

Authors:  Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; Masahiro Kobayashi; Mariko Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  J Med Virol       Date:  2011-06       Impact factor: 2.327

6.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.

Authors:  Michelle Spaan; Gertine van Oord; Kim Kreefft; Jun Hou; Bettina E Hansen; Harry L A Janssen; Robert J de Knegt; Andre Boonstra
Journal:  J Infect Dis       Date:  2015-07-28       Impact factor: 5.226

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.